Oğuz Abdullah Uyaroğlu

Dr. Oğuz Abdullah Uyaroğlu is an internist working at Hacettepe University Faculty of Medicine in General Internal Medicine Unit (Ankara, Turkey). His research area mainly consists of acute care and adult chronic diseases (Diabetes, Hypertension, Dyslipidemia, Obesity, Cardiovasculary Disease). He is serving as the consultant of the Acute and Emergency Care Units, mainly admitting elderly patients with acute decompensation of chronic diseases; lower respiratory tract infections, organ failure, and acute, undiagnosed conditions. Cardiovascular Risk and Preventive Medicine, Internal Medicine Specialization training and POCUS are his special interests.

He studied and trained on Point of Care Ultrasound (POCUS) in Internal Medicine with Prof. Juan Torres Macho and his team at the Internal Medicine Clinic of the Hospital Universitario Infanta Leonor Hospital in Madrid, Spain between January and June 2023.

He is the representative of Turkey (Turkish Society of Internal Medicine) in the Young Internist (YI) group of the European Federation of Internal Medicine (EFIM) and also a member of the Ultrasound Working Group of the EFIM.

He is a member of the Turkish Medical Association and the Turkish Society of Internal Medicine.

1. Two Overlooked Issues in Hypertension Management: Risk Thresholds and Obesity Integration Hipertansiyon Tedavisinde Gözden Kaçan İki Konu: Risk Eşikleri ve Obezitenin Tedaviye Dahil EdilmesiUYAROĞLU O. A.Turk Kardiyoloji Dernegi Arsivi, cilt.54, sa.4, ss.363-364, 2026 (ESCI, Scopus, TRDizin)
2. Combined low-volume high-intensity interval training and inspiratory muscle training in patients with metabolic syndrome: A randomized controlled trialUyar H., VARDAR YAĞLI N., SAĞLAM M., ÇALIK E., UYAROĞLU O. A., ÖZDEDE M., et al.Medicine, cilt.105, sa.17, 2026 (SCI-Expanded, Scopus)
3. Effect of Type IV Resistant Starch-Enriched Breads on Appetite, Glycemic Index, and Glycemic ResponseTekin T., TAMER F., UYAROĞLU O. A., FİSUNOĞLU M.Starch/Staerke, cilt.78, sa.3, 2026 (SCI-Expanded, Scopus)
4. Obesity care in internal medicine: A gap between recognition and treatment competenceÇALIK BAŞARAN N., Yalcinkaya F., UYAROĞLU O. A., ÜNAL S.European Journal of Internal Medicine, 2026 (SCI-Expanded, Scopus)
5. Fast-tracking internal medicine: An American debate with European implicationsUYAROĞLU O. A.European Journal of Internal Medicine, 2026 (SCI-Expanded, Scopus)
6. Association between Hashimoto’s thyroiditis and hemoglobin-albumin-lymphocyte-platelet score and systemic inflammatory index: a nationwide cohort studyAtak Tel B. M., Biçer I., BAVUNOĞLU I., Düzen Oflas N., ŞAHİN TEKİN M., Sen H., et al.Postgraduate Medicine, cilt.138, sa.1, ss.63-70, 2026 (SCI-Expanded, Scopus)
7. Urinary Biomarker Profiles Define Divergent Pathways in Albuminuric and Non-Albuminuric Diabetic Kidney DiseaseKAYGUSUZ Y., Özbek D. A., ERDUT A., Abanoz R., Korkut M. G., ÖZDEDE M., et al.Kidney Diseases, cilt.12, sa.1, ss.330-345, 2026 (SCI-Expanded, Scopus)
8. Interplay of gut microbiome and metabolome in various blood pressure phenotypes based on ambulatory BP monitoring reveal new insights in nondipper patientsOzbek D. A., Koc N. S., Inal N., ERDOĞAN KABLAN S., KAYGUSUZ Y., KARAHAN S., et al.JOURNAL OF HYPERTENSION, cilt.43, sa.9, ss.1539-1553, 2025 (SCI-Expanded, Scopus)
9. The vaccination acceptance, confidence, and conviction on influenza in the Middle East, Eurasia, and Africa among healthcare providers (VACCIMENA-HCP) project 2023: Determinants of vaccination behaviorDURUSU TANRIÖVER M., Vallee-Tourangeau G., Kokorin V. A., Larina V. N., Maamar M., Harmouche H., et al.IJID REGIONS, cilt.14, 2025 (ESCI, Scopus)
10. Treatment of hospitalized patient with hyperglycemia: An EFIM critically appraised and adapted guidelineUYAROĞLU O. A., Ruza I., Skrha J., Patoulias D., Bevc S., Bojadjiev B. I., et al.EUROPEAN JOURNAL OF INTERNAL MEDICINE, cilt.132, ss.27-36, 2025 (SCI-Expanded, Scopus)
11. Could calisthenic exercises improve maximal exercise capacity, peripheral muscle strength and quality of life in dyslipidemia?Ozdemir F., SAĞLAM M., AKSEL UYLAR A. A., UYAROĞLU O. A., Basaran N. c., DURUSU TANRIÖVER M., et al.PLOS ONE, cilt.20, sa.6, 2025 (SCI-Expanded, Scopus)
12. Influenza Surveillance Under the Shadow of COVID-19 Pandemic: Phylogenetic Analysis of Influenza A (H1N1)pdm09 Viruses in Türkiye in 2019-20 SeasonGorkem E. R. A., Cubuk C., DURUSU TANRIÖVER M., BAĞCI BOSI A. T., Holyavkin C., ÖZIŞIK L., et al.FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.29, sa.4, ss.488-501, 2024 (ESCI, TRDizin)
13. Oxygen uptake efficiency, chronotropic ıncompetence and abnormal heart rate recovery during exercise in individuals with metabolic syndromeSANVER M. F., Uyar H., SAĞLAM M., ÇALIK KÜTÜKCÜ E., UYAROĞLU O. A., ÖZDEDE M., et al.EUROPEAN RESPIRATORY JOURNAL, 2024 (SCI-Expanded, Scopus)
14. Exercise Capacity, Muscle Function, Functional Balance, and Cognitive Status in Patients with Post COVID-19 Syndrome Compared to Healthy ControlsÖKSÜZ ÇAPANOĞLU M. Ş., UYAROĞLU O. A., VARDAR YAĞLI N., SAĞLAM M., İNAL İNCE D., ÖZIŞIK L., et al.Karya Journal of Health Science, cilt.5, ss.51-56, 2024 (TRDizin)
15. A potential prognostic indicator in methanol intoxication: Body temperatureBATUR A., UYAROĞLU O. A., KARALAR G., AKKAŞ M.Acta Medica, cilt.55, sa.2, ss.128-136, 2024 (TRDizin)
16. Tuberculosis- The master of disguise: A case of disseminated tuberculosis masquerading as metastatic cancerSahin Mavi E. A., AKDEMİR M. Ç., Akin A. E., UYAROĞLU O. A., KÖKSAL D.TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, cilt.72, sa.2, ss.167-172, 2024 (ESCI, Scopus, TRDizin)
17. Don't ignore the internists; Who do you think holds the holy grail?UYAROĞLU O. A.European Journal of Internal Medicine, cilt.122, ss.121, 2024 (SCI-Expanded, Scopus)
18. Evaluation of infectious diseases physicians' attitudes to dyslipidemia management in PLWHBALLI TURHAN F. N., KARA E., UYAROĞLU O. A., ÇALIK BAŞARAN N., DEMİRKAN S. K., ÜNAL S., et al.POSTGRADUATE MEDICINE, cilt.136, ss.720-725, 2024 (SCI-Expanded, Scopus)
19. Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event predictionGüven A. T., ÖZDEDE M., Şener Y. Z., Yıldırım A. O., Altıntop S. E., YEŞİLYURT B., et al.European Journal of Internal Medicine, cilt.114, ss.74-83, 2023 (SCI-Expanded, Scopus)
20. High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approachBÖLEK H., ÇETİK S., CEYLAN F., BÖLEK E. Ç., UYAROĞLU O. A., TANRIÖVER M. D.Acta Medica, cilt.54, sa.2, ss.116-126, 2023 (TRDizin)
21. The Collateral Benefit of COVID Pandemic: Improved Pharmacological Venous Thromboembolism Prophylaxis Practices in Non-COVID PatientsÖZDEDE M., Güven A. T., DURUSU TANRIÖVER M., Güven D. K., UYAROĞLU O. A.International Journal of General Medicine, cilt.16, ss.1069-1079, 2023 (SCI-Expanded, Scopus)
22. Can PNI and CONUT Scores Predict One-year Survival Both in Older and Younger Hospitalized Patients with COVID-19?ÖZTÜRK Y., ÖZDEDE M., UYAROĞLU O. A., GÜNER OYTUN M., CEYLAN S., HALİL M. G.European journal of geriatrics and gerontology (Online), cilt.4, sa.3, ss.166-172, 2022 (Scopus, TRDizin)
23. Evaluation of Sarcopenia in COVID-19 Survivors: A Common But Overlooked ProblemCEYLAN S., ÖZTÜRK Y., GÜNER OYTUN M., OKYAR BAŞ A., KOCA M., ÜNSAL P., et al.Clinical Science of Nutrition, cilt.4, sa.2, ss.46-53, 2022 (Hakemli Dergi)
24. Independent predictors of in-hospital mortality and the need for intensive care in hospitalized non-critical COVID-19 patients: a prospective cohort studyÇALIK BAŞARAN N., ÖZDEDE M., UYAROĞLU O. A., ŞAHİN T. K., ÖZCAN B., ORAL H., et al.INTERNAL AND EMERGENCY MEDICINE, cilt.17, sa.5, ss.1413-1424, 2022 (SCI-Expanded, Scopus)
25. Longitudinal Assessment of Anti-Spike-1 antibody Responses in a Group of Hospitalized Patients with SARS-CoV-2 InfectionÖZDEDE M., UYAROĞLU O. A., DURUSU TANRIÖVER M., SAİN GÜVEN G., ŞENER B., Zarakolu P.MIKROBIYOLOJI BULTENI, cilt.56, sa.3, ss.553-566, 2022 (SCI-Expanded, Scopus, TRDizin)
26. Bacterial Bloodstream Infection in Renal Transplant Recipients: 15 years of experience in a university hospitalÇALIK BAŞARAN N., ÖZYAVUZ ALP Ş., ASLAN A. T., PAHSAYEV T., YILDIRIM T., YILMAZ Ş. R., et al.ERCIYES MEDICAL JOURNAL, 2022 (ESCI, TRDizin)
27. Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched StudyUYAROĞLU O. A., SÖNMEZER M. Ç., TELLİ DİZMAN G., ÇALIK BAŞARAN N., KARAHAN S., UZUN Ö.Acta Medica, cilt.53, sa.1, ss.73-82, 2022 (TRDizin)
28. Do We Properly Manage Smoking Cessation as a Part of Our Daily Practice? A Pilot Study from a University HospitalÇALIK BAŞARAN N., ÖZIŞIK L., UYAROĞLU O. A., DURUSU TANRIÖVER M., ÖZ Ş. G., Guven G. S.CYPRUS JOURNAL OF MEDICAL SCIENCES, cilt.7, sa.1, ss.109-114, 2022 (ESCI, TRDizin)
29. A COVID-19 first evaluation clinic at a university hospital in Turkey.Telli Dizman G., Metan G., Ayaz Ceylan Ç. M., Altunay H., Uzun M., Gürsoy G., et al.Turkish journal of medical sciences, cilt.52, sa.1, ss.1-10, 2022 (SCI-Expanded, Scopus, TRDizin)
30. Characteristics and management of asymptomatic SARS-CoV-2 infectionsDURUSU TANRIÖVER M., Fathi A., Matthias Raspe M., Grilo Novais, A., UYAROĞLU O. A.JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, cilt.33, sa.1, ss.1-7, 2022 (Scopus)
31. Hyperlipidemia in Post-COVID patients; a unique observational follow-up study on lipid levels in post-COVID patientsUYAROĞLU O. A., ÖZDEDE M., ÇALIK BAŞARAN N., KÖYLÜ B., ŞAHİN T. K., ÖZIŞIK L., et al.JOURNAL OF HEALTH SCIENCES AND MEDICINE, cilt.5, sa.1, ss.220-226, 2022 (TRDizin)
32. This is not Only a Question, But Also an Invitation; Are Infectious Disease Specialists" Choosing Wisely"?UYAROĞLU O. A., UZUN Ö.Infectious diseases and clinical microbiology (Online), cilt.4, sa.2, ss.148-149, 2022 (TRDizin)
33. A Rare Cause of Respiratory Failure: Negative Pressure Pulmonary EdemaSAYINALP B., UYAROĞLU O. A.Respiratory Case Reports, cilt.11, sa.2, ss.69-72, 2022 (TRDizin)
34. COVID-19, parvovirus and acute HIV infection in the gamut of diagnosis of fever and rashUYAROĞLU O. A., ÖZIŞIK L., ÇALIK BAŞARAN N., Telli Dizman G., Tas Z., ÖZDEDE M., et al.MARMARA MEDICAL JOURNAL, cilt.35, sa.1, ss.115-120, 2022 (ESCI, Scopus, TRDizin)
35. "COVID-19: The final nail in the coffin for physical examination" Evaluation of the effects of COVID-19 pandemic on physical examination habits of residents in a university hospital: A cross-sectional surveyERDEVİR M., UYAROĞLU O. A., ÖZDEDE M., DURUSU TANRIÖVER M.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, cilt.75, sa.12, 2021 (SCI-Expanded, Scopus)
36. Evaluation of Corrected QT Intervals of 74 COVID19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or FavipiravirUYAROĞLU O. A., ŞENER Y. Z., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., ŞAHİN T. K., et al.European Journal of Therapeutics, cilt.27, sa.4, ss.311-317, 2021 (ESCI, TRDizin)
37. 'Anxiety is still ongoing!' Evaluation of the effect of the COVID-19 pandemic on anxiety severity of physicians working in the internal medicine department after 1 year: a collaborative cross-sectional studyUYAROĞLU O. A., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., DURUSU TANRIÖVER M., Guven G. S.INTERNAL MEDICINE JOURNAL, cilt.51, sa.11, ss.1940-1945, 2021 (SCI-Expanded, Scopus)
38. Reliability and validity of the Turkish version of Post-COVID-19 Functional Status ScaleÇALIK KÜTÜKCÜ E., ÇAKMAK A., Kinaci E., UYAROĞLU O. A., VARDAR YAĞLI N., SAİN GÜVEN G., et al.Turkish journal of medical sciences, cilt.51, sa.5, ss.2304-2310, 2021 (SCI-Expanded, Scopus, TRDizin)
39. Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival BleedingYALÇINKAYA F., UYAROĞLU O. A.JOURNAL OF EMERGENCY MEDICINE CASE REPORTS, cilt.12, sa.3, ss.85-87, 2021 (ESCI)
40. First Confirmed Cases of 2019 Novel Coronavirus in a University Hospital in Turkey: Housemate InternistsUYAROĞLU O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., TAŞ Z., TELLİ DİZMAN G., İNKAYA A. Ç., et al.Acta Medica, cilt.52, sa.1, ss.75-81, 2021 (TRDizin)
41. QuantiFERON (R)-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guerin (BCG)-vaccinated country: the HUR-BIO single-center real-life resultsŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.CLINICAL RHEUMATOLOGY, cilt.40, sa.5, ss.2027-2035, 2021 (SCI-Expanded, Scopus)
42. COVID-19 at First Glance, Pulmonary Tuberculosis With a Glance in DepthUYAROĞLU O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., İNKAYA A. Ç., Guven G. S.JOURNAL OF EMERGENCY MEDICINE CASE REPORTS, cilt.12, sa.1, ss.22-24, 2021 (ESCI)
43. Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center studyUyaroĞlu O. A., BaŞaran N. Ç., ÖziŞik L., Dİzman G., EroĞlu İ., Şahİn T. K., et al.INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, cilt.33, sa.1, 2021 (SCI-Expanded, SSCI, Scopus)
44. Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patientsİNKAYA A. Ç., KARA E., ÇALIK BAŞARAN N., ŞAHİN T. K., UYAROĞLU O. A., UZUN Ö., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.5, ss.2786-2788, 2021 (SCI-Expanded, Scopus, TRDizin)
45. Güncel Veriler Işığında COVID-19 ve Renin Anjiyotensin Aldosteron Sistemi İlişkisiEROĞLU İ., UYAROĞLU O. A., SAİN GÜVEN G.Osmangazi Tıp Dergisi, cilt.43, sa.1, ss.86-93, 2021 (TRDizin)
46. Quality gap in venous thromboembolism prophylaxis practices in inpatients: Assessment of prophylaxis practices in a University HospitalGÜVEN A. T., ALTINTOP S. E., ÖZDEDE M., UYAROĞLU O. A., DURUSU TANRIÖVER M.INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, cilt.33, sa.3, 2021 (SCI-Expanded, SSCI, Scopus)
47. We know the problem, now it is time to find a solution: supporting residents during the COVID-19 pandemic ReplyUYAROĞLU O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., KARAHAN S., DURUSU TANRIÖVER M., Guven G. S., et al.INTERNAL MEDICINE JOURNAL, cilt.51, sa.1, ss.156, 2021 (SCI-Expanded, Scopus)
48. Two separate and important points that should not be forgotten among the consequences of the pandemic: psychology of healthcare workers and readmission of discharged COVID-19 patientsUYAROĞLU O. A.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.3, ss.1596-1597, 2021 (SCI-Expanded, Scopus, TRDizin)
49. Vaccination Rates and Adherence to Guidelines in Splenectomy Patients: An Observational Cross-sectional StudyÇALIK BAŞARAN N., ÖZIŞIK L., UYAROĞLU O. A., DURUSU TANRIÖVER M., KARAKOÇ D., SAİN GÜVEN G., et al.FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.25, sa.4, ss.589-594, 2020 (ESCI, TRDizin)
50. Addressing Influenza Vaccination in MENA Region during the COVID-19 Pandemic: Decreasing the Effects of the CollisionAWAIDY S. A., UYAROĞLU O. A., WANNOUS C., DURUSU TANRIÖVER M.OMAN MEDICAL JOURNAL, cilt.35, sa.6, 2020 (Scopus)
51. Evaluation of the effect ofCOVID-19 pandemic on anxiety severity of physicians working in the internal medicine department of a tertiary care hospital: a cross-sectional surveyUYAROĞLU O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., KARAHAN S., DURUSU TANRIÖVER M., SAİN GÜVEN G., et al.INTERNAL MEDICINE JOURNAL, cilt.50, sa.11, ss.1350-1358, 2020 (SCI-Expanded, Scopus)
52. Safra kesesi agenezi; safra yollarının nadir görülen bir anomalisiUYAROĞLU O. A.Akademik Gastroenteroloji Dergisi, cilt.19, sa.1, ss.38-39, 2020 (TRDizin)
53. Pregnancy outcomes in partners of male ankylosing spondylitis patients treated with anti-tumour necrosis factor-alpha biologics: real-life results from a single-centre cross-sectional studyUYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.RHEUMATOLOGY INTERNATIONAL, cilt.40, sa.9, ss.1501-1507, 2020 (SCI-Expanded, Scopus)
54. Can Levamisole be used in the treatment of COVID-19 patients presenting with diarrhea?UYAROĞLU O. A., SAİN GÜVEN G., Gullu I.JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.14, sa.8, ss.844-846, 2020 (SCI-Expanded, Scopus)
55. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?EROĞLU İ., ÇELİK EROĞLU B., UYAROĞLU O. A., SAİN GÜVEN G.ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.24, sa.1, ss.19-20, 2020 (SCI-Expanded, Scopus, TRDizin)
56. Asemptomatik kreatin kinaz (CK) yüksekliği: Hiper-CK-emiUYAROĞLU O. A.CUKUROVA MEDICAL JOURNAL, cilt.45, sa.2, ss.756-757, 2020 (ESCI, TRDizin)
57. The Role and Importance of Chronic Diseases in COVID-19 and Related RecommendationsSandalci B., UYAROĞLU O. A., SAİN GÜVEN G.FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.25, sa.2, ss.132-138, 2020 (ESCI, TRDizin)
58. Asemptomatik kreatin kinaz (CK) yuksekligi: Hiper-CK-emiUYAROĞLU O. A.CUKUROVA MEDICAL JOURNAL, cilt.45, sa.2, ss.756-757, 2020 (ESCI, TRDizin)
59. Behcet's disease; A rare refractory patient with vena cava superior syndrome treated with infliximab: a case report and review of the literatureUyaroglu O. A., ERDEN A., KILIÇ L., PEYNİRCİOĞLU B., KARADAĞ Ö., KALYONCU U.ACTA CLINICA BELGICA, cilt.74, sa.5, ss.364-369, 2019 (SCI-Expanded, Scopus)
60. Frequency of Behcet's disease among a group of visually impaired adultsUYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., Vahabov C., BABAOĞLU H., ARMAĞAN B., et al.IRISH JOURNAL OF MEDICAL SCIENCE, cilt.188, sa.1, ss.333-336, 2019 (SCI-Expanded, Scopus)

All 62 on AVESİS →

1. Exploring the interplay between gut microbiome, fecal metabolomics and ambulatory blood pressure in white-coat hypertensive patientsÖZBEK D. A., KOÇ N. S., nal N. e., ERDOĞAN KABLAN S., KAYGUSUZ Y., KARAHAN S., et al.61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)
2. SS-044 BETY-BQ ÖLÇEĞİNİN TİP 2 DİABETES MELLUTUS TANILI BİREYLERDE GEÇERLİĞİ VE GÜVENİRLİĞİNİN İNCELENMESİ –PİLOT ÇALIŞMATüfekçi O., BURAN S., KARACA N. B., ÖZDEDE M., UYAROĞLU O. A., ÜNAL E., et al.25. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 8 - 12 Kasım 2023, ss.69-70, (Özet Bildiri)
3. COVID-19 TANISIYLA İZLENEN HASTALARIN HASTALIKLA İLGİLİ RİSK ALGILARI VE YAŞAM TARZI DEĞİŞİKLİĞİ PLANLARININ DEĞERLENDİRİLMESİZARNİSHANOV K., UYAROĞLU O. A., ÇALIK BAŞARAN N., SAİN GÜVEN G.25. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 8 - 12 Kasım 2023, (Tam Metin Bildiri)
4. COVID-19 Tanısı ile Servis ve Yoğun Bakım Ünitelerinde İzlenen Hastaların İmmünolojik Özelliklerinin KarşılaştırılmasıÇALIK BAŞARAN N., TAN Ç., UYAROĞLU O. A., DEĞİRMENCİLER R. F., TELLİ DİZMAN G., ÖZBEK B., et al.23. Ulusal İç Hastalıkları Kongresi, Girne, Kıbrıs (Kktc), 06 Ekim 2021, ss.38-39, (Özet Bildiri)
5. Can plasma lipid levels be correlated to severe COVID-19 infection?UYAROĞLU O. A., ÖZDEDE M., ÇALIK BAŞARAN N., KÖYLÜ B., ŞAHİN T. K., ÖZIŞIK L., et al.Atherosclerosis, Helsinki, Finlandiya, 28 Haziran 2021, (Özet Bildiri)
6. Post-COVID-19 Hastalarında Nefes Darlığı, Periferik Kas Kuvveti ve Egzersiz Kapasitesi’nin COVID-19 Geçirmemiş Sağlıklı Bireylerle KarşılaştırılmasıÖksüz M. Ş., ÇALIK KÜTÜKCÜ E., UYAROĞLU O. A., SAİN GÜVEN G., VARDAR YAĞLI N., SAĞLAM M., et al.8. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Türkiye, 08 Mayıs 2021, (Özet Bildiri)
7. Psöriatik artrit hastalar›nda 5 yıllık anti-TNF alfa kullanımı sonrasında subklinik aterosklerozun değişimiERDEN A., CANPOLAT U., UYAROĞLU O. A., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.233-234, (Özet Bildiri)
8. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life ExperiencesUYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
9. Dislipidemi Tedavisinde Hekimlerin Kafası Karışık MıKARA E., ECEMİŞ S., TECEN K., UYAROĞLU O. A., ŞEYHOĞLU E., SELİMOVA C., et al.!8. ULUSAL İÇ HASTALIKLARI KONGRESİ, Türkiye, 12 - 16 Ekim 2016, (Özet Bildiri)
10. Metabolik Sendromlu Hastalarda Yüksek Yoğunluklu İnterval Eğitim ile Kombine Solunum Kas Eğitiminin EtkileriUYAR H., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., UYAROĞLU O. A., ÖZDEDE M., DURUSU TANRIÖVER M.
11. Factors Associated with Exercise Capacity and Functional Balance in Post-COVID-19 SyndromeÇALIK KÜTÜKCÜ E., ÖKSÜZ ÇAPANOĞLU M. Ş., UYAROĞLU O. A., VARDAR YAĞLI N., İNAL İNCE D., ÖZIŞIK L., et al.
12. İZOLE GGT YÜKSEKLİĞİNİN KARDİYOVASKÜLER HASTALIK RİSKİ VE METABOLİK SENDROM İLE İLİŞKİSİÖztürk Z. Ö., UYAROĞLU O. A., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., SAİN GÜVEN G., et al.
13. HIZLI İLERLEYEN AKUT BÖBREK HASARINDA NADİR BİR ETİYOLOJİ: GOODPASTURE SENDROMUÇEŞMECİ E., FEDAİ A. B., UYAROĞLU O. A., YILDIRIM T.
14. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life ResultsŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.

1. PATOFİZYOLOJİNİN TEMELLERİDURUSU TANRIÖVER M., SARI A., EŞME M., KOÇ YILDIRIM S., YILDIRIM M. Ş., BÖLEK E. Ç., et al.PALME YAYINCILIK, 2017
2. COVID-19 Sürecinde Kronik Hastalıkların YönetimiUYAROĞLU O. A., ÇALIK BAŞARAN N.